Pursuant to section 20 of the Medicines Act 1981, the Minister of Health gave his consent to the distribution in New Zealand of the new medicines listed in the Schedule to a notice published in the New Zealand Gazette, 28 October 2010, No. 46, page 3651.
This corrigendum amends the notice by replacing the entry for the product Sativex with the following entry:
"Product: Sativex
Active Ingredients: Cannabidiol 25mg/mL equivalent to cannabis sativa extract 35mg-42mg
Tetrahydrocannabinol 27mg/mL equivalent to cannabis sativa extract 36mg-44mg
Dosage Form: Oral spray
New Zealand Sponsor: Health Support Limited
Manufacturer: CP Pharmaceuticals Limited, Wrexham, United Kingdom"
Dated this 7th day of April 2011.
MARK JACOBS, Acting Chief Medical Officer, Clinical Leadership, Protection and Regulation, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).